These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26265781)

  • 1. Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs.
    Berges C; Bedke T; Stuehler C; Khanna N; Zehnter S; Kruhm M; Winter N; Bargou RC; Topp MS; Einsele H; Chatterjee M
    J Leukoc Biol; 2015 Dec; 98(6):1091-105. PubMed ID: 26265781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells.
    Berges C; Chatterjee M; Topp MS; Einsele H
    Immunol Res; 2016 Jun; 64(3):687-98. PubMed ID: 26724940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease.
    Stuehler C; Mielke S; Chatterjee M; Duell J; Lurati S; Rueckert F; Einsele H; Bargou RC; Topp MS
    Blood; 2009 Sep; 114(13):2829-36. PubMed ID: 19657113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling.
    Allgäuer A; Schreiner E; Ferrazzi F; Ekici AB; Gerbitz A; Mackensen A; Völkl S
    J Immunol; 2015 Oct; 195(7):3139-48. PubMed ID: 26324773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
    Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.
    Huang Q; He S; Tian Y; Gu Y; Chen P; Li C; Huang J; Liu Y; Yu H; Jin M; Hu S; Tong Q; Ma A; Jin J; Hexner E; Fung H; Reshef R; Zhang Y; Zhang Y
    Blood; 2017 May; 129(20):2737-2748. PubMed ID: 28246193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.
    Gloesenkamp C; Nitzsche B; Lim AR; Normant E; Vosburgh E; Schrader M; Ocker M; Scherübl H; Höpfner M
    Int J Oncol; 2012 May; 40(5):1659-67. PubMed ID: 22246317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
    Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
    Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study.
    Al-Homsi AS; Cole K; Bogema M; Duffner U; Williams S; Mageed A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1315-20. PubMed ID: 25765556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
    Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
    Avivi I; Stroopinsky D; Rowe JM; Katz T
    Transpl Immunol; 2013 Jan; 28(1):57-61. PubMed ID: 23196257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation.
    Pastore D; Delia M; Mestice A; Perrone T; Carluccio P; Gaudio F; Giordano A; Rossi AR; Ricco A; Leo M; Liso V; Specchia G
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):550-7. PubMed ID: 20457268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of graft-versus-host disease by regulatory T cells: which level of antigen specificity?
    Martinic MM; von Herrath MG
    Eur J Immunol; 2006 Sep; 36(9):2299-303. PubMed ID: 16952145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
    Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A
    Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation.
    McIver Z; Serio B; Dunbar A; O'Keefe CL; Powers J; Wlodarski M; Jin T; Sobecks R; Bolwell B; Maciejewski JP
    Br J Haematol; 2008 Apr; 141(2):170-8. PubMed ID: 18318770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.